318 related articles for article (PubMed ID: 10545286)
21. Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
Willette RN; Ohlstein EH; Mitchell MP; Sauermelch CF; Beck GR; Luttmann MA; Hay DW
J Pharmacol Exp Ther; 1997 Feb; 280(2):695-701. PubMed ID: 9023281
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of endothelin-1 and hypoxia-induced pulmonary pressor responses in the rat by a novel selective endothelin-A receptor antagonist, di-n-butylaminocarbamyl-L-leucyl-D-tryptophanyl-D-4-chloro-Phe.
Yan LD; Kong LL; Yong Z; Dong HJ; Chi MG; Pan XF; Zhang C; Liang YJ; Gong ZH; Liu KL
J Cardiovasc Pharmacol; 2010 Sep; 56(3):246-54. PubMed ID: 20531217
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary vascular pressure effects by endothelin-1 in normoxia and chronic hypoxia: a longitudinal study.
Tjen-A-Looi S; Ekman R; Osborn J; Keith I
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2246-53. PubMed ID: 8997280
[TBL] [Abstract][Full Text] [Related]
24. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats.
Eddahibi S; Raffestin B; Clozel M; Levame M; Adnot S
Am J Physiol; 1995 Feb; 268(2 Pt 2):H828-35. PubMed ID: 7864210
[TBL] [Abstract][Full Text] [Related]
25. Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension.
Schroll S; Arzt M; Sebah D; Stoelcker B; Luchner A; Budweiser S; Blumberg FC; Pfeifer M
Scand J Clin Lab Invest; 2008; 68(4):270-6. PubMed ID: 18612919
[TBL] [Abstract][Full Text] [Related]
26. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat.
McCulloch KM; Docherty C; MacLean MR
Br J Pharmacol; 1998 Apr; 123(8):1621-30. PubMed ID: 9605569
[TBL] [Abstract][Full Text] [Related]
27. The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats.
Elmedal B; de Dam MY; Mulvany MJ; Simonsen U
Br J Pharmacol; 2004 Jan; 141(1):105-13. PubMed ID: 14656807
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of 3-azabicyclo[3,2,1] octane-1-yl-l-leucyl-d-tryptophanyl-d-4-Cl-phenylalanine: A novel ET(A) receptor-selective antagonist.
Li X; Liu KL; Zheng JQ; Chi MG; Dong JJ; Dong SJ; Gong ZH
Pulm Pharmacol Ther; 2008 Oct; 21(5):780-7. PubMed ID: 18602014
[TBL] [Abstract][Full Text] [Related]
29. BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats.
Bonvallet ST; Zamora MR; Hasunuma K; Sato K; Hanasato N; Anderson D; Sato K; Stelzner TJ
Am J Physiol; 1994 Apr; 266(4 Pt 2):H1327-31. PubMed ID: 8184910
[TBL] [Abstract][Full Text] [Related]
30. Attenuation of pulmonary arterial smooth muscle cell proliferation following hypoxic pulmonary hypertension by the Na+/H+ exchange inhibitor amiloride.
Liu Y; Zhang B; Dong MQ; Niu W; Luo Y; Gao YQ; Li ZC
Chin J Physiol; 2010 Feb; 53(1):36-44. PubMed ID: 21789883
[TBL] [Abstract][Full Text] [Related]
31. ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat.
DiCarlo VS; Chen SJ; Meng QC; Durand J; Yano M; Chen YF; Oparil S
Am J Physiol; 1995 Nov; 269(5 Pt 1):L690-7. PubMed ID: 7491990
[TBL] [Abstract][Full Text] [Related]
32. The effect of the ETA receptor antagonist (CI-1020) in rats with established hypoxic pulmonary hypertension.
Sheedy W; Haleen S; Morice AH
Pulm Pharmacol Ther; 1998; 11(2-3):173-6. PubMed ID: 9918751
[TBL] [Abstract][Full Text] [Related]
33. [Study on relativity of hypoxic pulmonary hypertension with levels of endothelin-1 and vascular endothelial growth factor in plasma of pulmonary artery and carotid artery].
Huang YF; Li ZC; Luan LL; Dong MQ; Zhang B
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2007 Nov; 23(4):473-7. PubMed ID: 21180137
[TBL] [Abstract][Full Text] [Related]
34. Hypoxic exposure time dependently modulates endothelin-induced contraction of pulmonary artery smooth muscle.
Bialecki RA; Fisher CS; Murdoch WW; Barthlow HG; Stow RB; Mallamaci M; Rumsey W
Am J Physiol; 1998 Apr; 274(4):L552-9. PubMed ID: 9575873
[TBL] [Abstract][Full Text] [Related]
35. Neutral endopeptidase inhibition attenuates development of hypoxic pulmonary hypertension in rats.
Klinger JR; Petit RD; Warburton RR; Wrenn DS; Arnal F; Hill NS
J Appl Physiol (1985); 1993 Oct; 75(4):1615-23. PubMed ID: 8282611
[TBL] [Abstract][Full Text] [Related]
36. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
37. Reduction of chronic hypoxic pulmonary hypertension in the rat by beta-aminopropionitrile.
Kerr JS; Riley DJ; Frank MM; Trelstad RL; Frankel HM
J Appl Physiol Respir Environ Exerc Physiol; 1984 Dec; 57(6):1760-6. PubMed ID: 6511550
[TBL] [Abstract][Full Text] [Related]
38. Increased pulmonary prostacyclin synthesis in rats with chronic hypoxic pulmonary hypertension.
Blumberg FC; Lorenz C; Wolf K; Sandner P; Riegger GA; Pfeifer M
Cardiovasc Res; 2002 Jul; 55(1):171-7. PubMed ID: 12062720
[TBL] [Abstract][Full Text] [Related]
39. Antagonism of CXCR7 attenuates chronic hypoxia-induced pulmonary hypertension.
Sartina E; Suguihara C; Ramchandran S; Nwajei P; Rodriguez M; Torres E; Hehre D; Devia C; Walters MJ; Penfold ME; Young KC
Pediatr Res; 2012 Jun; 71(6):682-8. PubMed ID: 22337226
[TBL] [Abstract][Full Text] [Related]
40. Porcine pulmonary artery and bronchial responses to endothelin-1 and norepinephrine on recovery from hypoxic pulmonary hypertension.
Schindler MB; Hislop AA; Haworth SG
Pediatr Res; 2006 Jul; 60(1):71-6. PubMed ID: 16690956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
